The total number entries retrieved from this search are 452

ID	Name	Sequence	N-Terminal Modification	C-Terminal Modification	Chemical Modification	Linear/Cyclic	Length	Chirality	Nature	Source	Origin	Species	Strain	Inhibition Concentration	In vitro/ In vivo	Cell Line	Intracellular Inhibition	Cytotoxicity	Animal Model	Effective Dose in model organism	Immune Responce	Mechanism of Action	Target	Combination Therapy	Other Activities	Year of Publication	Pubmed ID/ Patent No.
antitb_2009	Api Ib RlO Hypll (Al 7 B2)	GNNRPVYIPR-41HyP-RPPHPRL	Free	Amidation	4tHyp= hydroxyprolin	Linear	18	L	Cationic	Synthetic	Mycobaclerium vaccae	Mycobacterium vaccae	Mycobacterium vaccae	MIC = 125	In vitro	NA	NA	NA	NA	NA	NA	NA	NA	NA	Anti bacterial against - Eschericha coli 45849 and D31, - Klebsiella pneumoniae 123132 and K6,Salmonella typhi S5 and Salmonella enterica subsp. enterica serovar Typhimurium, Rhizobium radiobacter, Klebsiella pneumoniae, Bactillus subtillis	2010	US 0222268 A1/E
antitb_2010	Api Ib K4 RlO Vl 9 (Al 8 Bl)	GNNKPVYIPRPRPPHPRLV	Free	Amidation	None	Linear	18	L	Cationic	Synthetic	Mycobaclerium vaccae	Mycobacterium vaccae	Mycobacterium vaccae	MIC = 125	In vitro	NA	NA	NA	NA	NA	NA	NA	NA	NA	Anti bacterial against - Eschericha coli 45849 and D31, - Klebsiella pneumoniae 123132 and K6,Salmonella typhi S5 and Salmonella enterica subsp. enterica serovar Typhimurium, Rhizobium radiobacter, Klebsiella pneumoniae, Bactillus subtillis	2010	US 0222268 A1/E